Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 2015

View Archived Issues

ValiRx acquires TRAC gene expression and biomarker technology

AstraZeneca supports Canadian National Access Project for Cancer Testing

Dermira releases phase IIb results of DRM-04

G1 Therapeutics completes Series B financing

Chronos Therapeutics establishes research collaboration with Kings College London

Adimab and Sanofi establish bispecific antibody collaboration

OnCore Biopharma describes license deal with NeuroVive in Tekmira Pharmaceutical merger document

Mitsubishi Tanabe Pharma updates activities of third quarter of fiscal 2014

Scientists identify new mutations amenable for therapeutic targeting in iCCA patients

Astellas Pharma reviews development highlights of third quarter of fiscal 2014

Sanofi presents highlights of fourth quarter 2014

Alkermes reports topline data from phase I study of ALKS-8700

Sodium channel modulators disclosed by Vertex Pharmaceuticals

Cadila Pharmaceuticals divulges agents for inflammation

FDA grants orphan drug status to tisagenlecleucel-T, copanlisib and ibrutinib for lymphomas

Cancer treatments receive FDA orphan drug status

Regulus Therapeutics reports topline data from RG-101 trial in HCV

Casi Pharmaceuticals reviews regulatory pathway for ENMD-2076

Epizyme patents EZH2 inhibitors

University of Texas discloses new sigma-receptor ligands

Boehringer Ingelheim Pharma presents new AMPK activators

Six-week ACH-3102/sofosbuvir regimen achieves 100% SVR12 in phase II study

STADApharm to launch Ebola rapid test

Roche acquires Signature Diagnostics

GSK and Theravance start second phase III trial of inhaled triple combination in COPD

LeafBio files IND application for Ebola virus therapeutic ZMapp

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...